Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Ovarian cancer and hormone replacement therapy in the Million Women study

Thumbnail Image

Date

2007

Authors

Beral, Valerie
Bull, Diana
Green, Jane
Reeves, Gillian K
Austoker, Joan
Banks, Emily
Church, Judith
English, Ruth
Patnick, Julietta
Vessey, Martin

Journal Title

Journal ISSN

Volume Title

Publisher

Lancet Publishing Group

Abstract

Background: Ovarian cancer is the fourth most common cancer in women in the UK, with about 6700 developing the malignancy and 4600 dying from it every year. However, there is limited information about the risk of ovarian cancer associated with the use of

Description

Keywords

Keywords: estrogen; gestagen; oral contraceptive agent; adult; alcohol consumption; article; body mass; cancer mortality; clear cell carcinoma; comparative study; controlled study; disease association; female; follow up; histology; hormone substitution; human; hyst

Citation

URI

http://hdl.handle.net/1885/51486

Collections

ANU Research Publications

Source

Lancet, The (UK edition)

Type

Journal article

Book Title

Entity type

Access Statement

License Rights

DOI

10.1016/S0140-6736(07)60534-0

Restricted until

2037-12-31

Downloads

File
Description
01_Beral_Ovarian_cancer_and_hormone_2007.pdf (6.28 MB)

DSpace software copyright © 2002-2026 LYRASIS